Product Images Anastrozole
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Anastrozole NDC 21695-990 by Rebel Distributors Corp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image of chemical structure - 611e1f43 1442 4cbb b7eb b65de15c6c70 01
image of figure 1 - 611e1f43 1442 4cbb b7eb b65de15c6c70 02
The text describes a figure showing the disease-free survival of patients randomized to receive either anastrozole or tamoxifen monotherapy in the ATAC trial. The figure presents a Kaplan Meier survival curve, with disease-free survival on the y-axis and time (in months) on the x-axis. The curve shows that disease-free survival was higher in patients who received anastrozole compared to tamoxifen. The figure also includes a table of the number of patients at risk at each time point.*
image of figure 2 - 611e1f43 1442 4cbb b7eb b65de15c6c70 03
The figure displays the Disease-free Survival of a hormone receptor-positive subpopulation of patients treated with Anastrozole versus Tamoxifen. The x-axis shows the duration of time (in months) and the y-axis represents the proportion of patients who remain alive and disease-free. It demonstrates that treatment with Anastrozole resulted in better disease-free survival compared to Tamoxifen. The number of patients at risk is also presented below the graph.*
image of figure 3 - 611e1f43 1442 4cbb b7eb b65de15c6c70 04
The figure shows the Kaplan-Meier probability of time to disease progression for patients who were randomized and treated in Trial 0030. The x-axis represents the time to progression in months while the y-axis represents the probability of disease progression. The graph compares the treatment response of the randomized groups who received Nastrozole and Tamoxifen. The figure also includes the number of patients at risk, at each time interval.*
image of figure 4 - 611e1f43 1442 4cbb b7eb b65de15c6c70 05
This text appears to be a figure from a medical trial (Trial 0027) showing the Kaplan-Meier probability of time to progression for randomized patients receiving treatment with an unspecified drug. The horizontal axis represents the time to progression, while the vertical axis shows the probability of progression. The treatment being evaluated in the trial is stated to be "wastrozole". The figure includes a graph of the Kaplan-Meier probability, as well as a table of the number of patients at risk at various time points.*
Anastrozole 1mg - 611e1f43 1442 4cbb b7eb b65de15c6c70 06
This appears to be the description of a medication called Anastrozole, which comes in the form of tablets that contain 1mg of the active ingredient. The tablets are white, round, and have an imprint code "AN;1". The product is manufactured by Natco Pharma Limited, based in Kothur-509 228. A.P. India, and the package ID is RA099030. It is recommended to store the medication at a controlled room temperature between 30°C (59°-86°F) and keep it out of reach of children.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.